Aardvark Therapeutics
AARD· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Tien-Li Lee, M.D. is the CEO of Aardvark Therapeutics and was paid $6.1M in FY2025 (Dec), up 569%.
PayNo stock prices for these years
Executives3
See all- 1Tien-Li Lee, M.D.Chief Executive OfficerFY2025
- 2Nelson SunChief Financial Officer and Chief Operating OfficerFY2025
- 3Manasi Jaiman, M.D., M.P.H.Chief Medical OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAardvark Therapeutics paid its 3 named executives $10.5M in total in FY2025 (Dec). CEO Tien-Li Lee, M.D. was paid $6.1M of that.
| Name | ||
|---|---|---|
| Tien-Li Lee, M.D.Chief Executive Officer | ||
| Nelson SunChief Financial Officer and Chief Operating Officer | Not disclosed | |
| Manasi Jaiman, M.D., M.P.H.Chief Medical Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Aardvark Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board3
See all- Roy D. Baynes, M.D., Ph.D.Director · 1 yr on the boardIndependentCompensation—Paid as an executive
- Susan E. GrafDirector · 1 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
- Victor Tong, Jr.Director · 1 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings3
See all| Proxy statement | DEF 14A | Jul 10, 2026 | FY2025 |
| Annual report | 10-K | Mar 23, 2026 | FY2025 |
| Annual report | 10-K | Mar 31, 2025 | FY2024 |
